Skip to content

Ayurveda balm for migraine.

Modification of rasnadi lepa into rasnadi balm And its clinical study in ardhavabhedaka(migraine). - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065610
Enrollment
10
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

CCRAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who fulfill the diagnostic criteria. 2. Patient of either gender of age between 18-60 years. 3. Both fresh and treated case will be considered for the study.

Exclusion criteria

Exclusion criteria: 1. Migraine with aura. 2. Severe depression or psychiatric disorders. 3. Referred pain in one half of head due to disorders of ear, eye, nose, teeth and neck. 4. Unilateral headache due to sinusitis, hypertension. 5.Patients who are using drugs like alcohol, chlorpromazine, hydrochlorothiazide, anti-anxiety agents, antidepressants, antipsychotics, antispasmodics, antihistamines and diuretics. 6.Patients under continuation of other system of medication for migraine. 7.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Patients get relief from migraine pain.Timepoint: Patients get relief from migraine pain within 90minutes.

Secondary

MeasureTime frame
There will be standardised form of rasnadhi lepa for regular use.Timepoint: 1 months

Countries

India

Contacts

Public ContactYashwanth raj h r

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan

dr.sushant99@gmail.com9036524877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026